<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2017-06-23" updated="2020-01-02">
  <drugbank-id primary="true">DB13761</drugbank-id>
  <name>Tilactase</name>
  <description>Tilactase is a beta-D-galactosidase obtained from _Aspergillus oryzae_. It is produced as a chewable tablet that has to be taken before the consumption of a lactose-containing meal.[A27172] The beta-D-galactosidase us a large monomeric multi-domain enzyme of 985 residues that presents a catalytic (alpha/beta)8-barrel domain.[A32591] It is considered by the WHO as part of the International Nonpropietary Names for Pharmaceutical Substances.[L2338]</description>
  <cas-number>9031-11-2</cas-number>
  <unii>37515NWH9U</unii>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A27172</ref-id>
        <pubmed-id>19021701</pubmed-id>
        <citation>Portincasa P, Di Ciaula A, Vacca M, Montelli R, Wang DQ, Palasciano G: Beneficial effects of oral tilactase on patients with hypolactasia. Eur J Clin Invest. 2008 Nov;38(11):835-44. doi: 10.1111/j.1365-2362.2008.02035.x.</citation>
      </article>
      <article>
        <ref-id>A27173</ref-id>
        <pubmed-id>2502573</pubmed-id>
        <citation>DiPalma JA, Collins MS: Enzyme replacement for lactose malabsorption using a beta-D-galactosidase. J Clin Gastroenterol. 1989 Jun;11(3):290-3.</citation>
      </article>
      <article>
        <ref-id>A32591</ref-id>
        <pubmed-id>23688418</pubmed-id>
        <citation>Maksimainen MM, Lampio A, Mertanen M, Turunen O, Rouvinen J: The crystal structure of acidic beta-galactosidase from Aspergillus oryzae. Int J Biol Macromol. 2013 Sep;60:109-15. doi: 10.1016/j.ijbiomac.2013.05.003. Epub 2013 May 17.</citation>
      </article>
      <article>
        <ref-id>A32592</ref-id>
        <pubmed-id>26715083</pubmed-id>
        <citation>Vandenplas Y: Lactose intolerance. Asia Pac J Clin Nutr. 2015;24 Suppl 1:S9-13.</citation>
      </article>
      <article>
        <ref-id>A32597</ref-id>
        <pubmed-id>26396367</pubmed-id>
        <citation>Selvarajan E, Mohanasrinivasan V: Kinetic studies on exploring lactose hydrolysis potential of beta galactosidase extracted from Lactobacillus plantarum HF571129. J Food Sci Technol. 2015 Oct;52(10):6206-17. doi: 10.1007/s13197-015-1729-z. Epub 2015 Jan 16.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2338</ref-id>
        <title>WHO</title>
        <url>http://apps.who.int/medicinedocs/index/assoc/h5775e/h5775e.pdf</url>
      </link>
      <link>
        <ref-id>L2340</ref-id>
        <title>Australian Complementary Medicines Evaluation</title>
        <url>https://www.tga.gov.au/sites/default/files/cmec-minutes-47.pdf</url>
      </link>
      <link>
        <ref-id>L2345</ref-id>
        <title>Lacdigest monograph</title>
        <url>https://compendium.ch/mpro/mnr/23598/html/fr?Platform=Desktop</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Tilactase is indicated for the symptomatic treatment of lactose intolerance in infants and older patients requiring a parenteral nutrition or fluid diet.[L2338]&#13;
&#13;
Lactose intolerance occurs when there is an existence of an inability to break down lactose which is commonly found in dairy products. This inability occurs when the lactase levels are reduced and thus there is no via to digest and break down the lactose. The undigested lactose moves into the large intestine where normal flora bacteria can interact with it and cause bloating, gas and diarrhea.[A32592] </indication>
  <pharmacodynamics>The use of a single oral administration of tilactase has been shown to be highly effective in decreasing the symptoms and hydrogen excretion of hypolactasia in tests of lactose H(2)-breath. The analysis has shown a decrease of approximately 80% in both malabsorbers and intolerants.[A27172]The administration of tilacatase also decreases the presence of bloating and flatus.[A27173]</pharmacodynamics>
  <mechanism-of-action>Lactose is the primary disaccharide found in dairy products. Tilactase is a type of lactase which is the enzyme that is in charge of the breakdown of lactose to glucose and galactose which can be used by the body.[L2340] Basically, tilactase acts by replacing the missing lactase in the body and allows avoidance of the reach of lactose to the small intestine and the normal bacteria and thus, preventing the symptoms of the lactose intolerance. Once tilactase has metabolized the lactose, the metabolism products are reabsorbed by the normal process of digestion.[L2345]</mechanism-of-action>
  <toxicity>Tilactase is known to present a low acute oral toxicity in preclinical trials. The lowest toxic dose for subcutaneous exposure is of 26 g/kg administered over 30 days.[L2340] There have not been performed enough studies regarding the use of pregnancy or related to the fetal development. There are no reports of overdose with tilactase.[L2345]</toxicity>
  <metabolism>Tilactase is degraded by the stomach acid and by the normal flora bacterial metabolism.[L2345] </metabolism>
  <absorption>Tilactase is not absorbed in the GI tract and thus the pharmacokinetic parameters related to absorption are not relevant.[L2345]</absorption>
  <half-life>Tilactase half-life at 35ÂºC is registered to be 123.77 min. This half-life can be affected by temperature in an inversely proportional manner.[A32597]</half-life>
  <protein-binding>Tilactase is not absorbed and thus the plasma protein binding is not possible.</protein-binding>
  <route-of-elimination>Tilactase is completely eliminated in the feces either unchanged or as metabolites.[L2345]</route-of-elimination>
  <volume-of-distribution>Tilactase is not absorbed and thus the volume of distribution is not relevant.</volume-of-distribution>
  <clearance>Tilactase is not absorbed and thus the clearance rate is not relevant.</clearance>
  <classification>
    <description/>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Organic Compounds</kingdom>
    <superclass>Organic Acids</superclass>
    <class>Carboxylic Acids and Derivatives</class>
    <subclass>Amino Acids, Peptides, and Analogues</subclass>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">beta-D-Galactosidase</synonym>
    <synonym language="english" coder="">beta-Galactosidase</synonym>
    <synonym language="english" coder="usp">Lactase</synonym>
    <synonym language="spanish" coder="">Tilactasa</synonym>
    <synonym language="english" coder="inn">Tilactase</synonym>
    <synonym language="latin" coder="">Tilactasum</synonym>
  </synonyms>
  <products>
    <product>
      <name>Dairy Digestive Aid Tab 3000fcc Lactase Unit</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02098962</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Extra Strength Lactaid Tablets - 4500fcclu</name>
      <labeller>Lactaid Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02193043</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2000-05-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lactace Cap 3400unit</name>
      <labeller>Nature's Way Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00833363</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lactaid Tab 3000unit</name>
      <labeller>Lactaid Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00674656</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2000-05-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lactaid Tab 3300unit</name>
      <labeller>Mcneil Consumer Healthcare Division Of Johnson &amp; Johnson Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01936859</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lactase 3400 Fcc Units Cap</name>
      <labeller>Attogram Corp</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02039737</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1996-08-16</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lactase Enzyme</name>
      <labeller>Holista Health (Canada) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02156512</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-05-08</started-marketing-on>
      <ended-marketing-on>2001-08-01</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lactase Enzyme</name>
      <labeller>Holista Health (Canada) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237790</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-04-13</started-marketing-on>
      <ended-marketing-on>2002-08-06</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lactase Enzyme Tablets 3300 Lac Units</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02222698</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-11-23</started-marketing-on>
      <ended-marketing-on>2009-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lacteeze Tablets - Extra Strength</name>
      <labeller>Gelda Scientific and Industrial Development Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239638</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Milk Aid</name>
      <labeller>Swiss Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243600</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-02-28</started-marketing-on>
      <ended-marketing-on>2001-08-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Milk Aid - Tab 500mg</name>
      <labeller>Swiss Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02171309</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2000-04-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Dairyaid</name>
      <company>Major Pharmaceuticals</company>
    </international-brand>
    <international-brand>
      <name>Lacdigest</name>
      <company/>
    </international-brand>
    <international-brand>
      <name>Oryzatym</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Lactace Cap 3400unit</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Lactaid Tab 3300unit</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Lactase 3400 Fcc Units Cap</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Dairy Digestive Aid Tab 3000fcc Lactase Unit</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Milk Aid - Tab 500mg</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Extra Strength Lactaid Tablets - 4500fcclu</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Lactase Enzyme</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Lactase Enzyme Tablets 3300 Lac Units</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Lactase Enzyme</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Milk Aid</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Lactaid Tab 3000unit</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
    <mixture>
      <name>Lacteeze Tablets - Extra Strength</name>
      <ingredients>Tilactase</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antifoaming Agents</category>
      <mesh-id>D000934</mesh-id>
    </category>
    <category>
      <category>beta-Galactosidase</category>
      <mesh-id>D001616</mesh-id>
    </category>
    <category>
      <category>beta-Galactosidase, antagonists &amp; inhibitors</category>
      <mesh-id/>
    </category>
    <category>
      <category>Digestives, Incl. Enzymes</category>
      <mesh-id/>
    </category>
    <category>
      <category>Enzyme Preparations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Enzymes</category>
      <mesh-id>D004798</mesh-id>
    </category>
    <category>
      <category>Enzymes and Coenzymes</category>
      <mesh-id>D045762</mesh-id>
    </category>
    <category>
      <category>Galactosidases</category>
      <mesh-id>D005696</mesh-id>
    </category>
    <category>
      <category>Gastrointestinal Agents</category>
      <mesh-id>D005765</mesh-id>
    </category>
    <category>
      <category>Glycoside Hydrolases</category>
      <mesh-id>D006026</mesh-id>
    </category>
    <category>
      <category>Hydrolases</category>
      <mesh-id>D006867</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="A09AA04">
      <level code="A09AA">Enzyme preparations</level>
      <level code="A09A">DIGESTIVES, INCL. ENZYMES</level>
      <level code="A09">DIGESTIVES, INCL. ENZYMES</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>44:00.00</ahfs-code>
    <ahfs-code>56:10.00</ahfs-code>
    <ahfs-code>56:16.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB13761.pdf?1524004190</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences>
    <sequence format="FASTA">&gt;tr|B7VU80|B7VU80_ASPOZ Beta-galactosidase OS=Aspergillus oryzae OX=5062 GN=lacA PE=2 SV=1&lt;&lt;
MKLLSVAAVALLAAQAAGASIKHRLNGFTILEHPDPAKRDLLQDIVTWDDKSLFINGERI
MLFSGEVHPFRLPVPSLWLDIFHKIRALGFNCVSFYIDWALLEGKPGDYRAEGIFALEPF
FDAAKEAGIYLIARPGSYINAEVSGGGFPGWLQRVNGTLRSSDEPFLKATDNYIANAAAA
VAKAQITNGGPVILYQPENEYSGGCCGVKYPDADYMQYVMDQARKADIVVPFISNDASPS
GHNAPGSGTSAVDIYGHDSYPLGFDCANPSVWPEGKLPDNFRTLHLEQSPSTPYSLLEFQ
AGAFDPWGGPGFEKCYALVNHEFSRVFYRNDLSFGVSTFNLYMTFGGTNWGNLGHPGGYT
SYDYGSPITETRNVTREKYSDIKLLANFVKASPSYLTATPRNLTTGVYTDTSDLAVTPLI
GDSPGSFFVVRHTDYSSQESTSYKLKLPTSAGNLTIPQLEGTLSLNGRDSKIHVVDYNVS
GTNIIYSTAEVFTWKKFDGNKVLVLYGGPKEHHELAIASKSNVTIIEGSDSGIVSTRKGS
SVIIGWDVSSTRRIVQVGDLRVFLLDRNSAYNYWVPELPTEGTSPGFSTSKTTASSIIVK
AGYLLRGAHLDGADLHLTADFNATTPIEVIGAPTGAKNLFVNGEKASHTVDKNGIWSSEV
KYAAPEIKLPGLKDLDWKYLDTLPEIKSSYDDSAWVSADLPKTKNTHRPLDTPTSLYSSD
YGFHTGYLIYRGHFVANGKESEFFIRTQGGSAFGSSVWLNETYLGSWTGADYAMDGNSTY
KLSQLESGKNYVITVVIDNLGLDENWTVGEETMKNPRGILSYKLSGQDASAITWKLTGNL
GGEDYQDKVRGPLNEGGLYAERQGFHQPQPPSESWESGSPLEGLSKPGIGFYTAQFDLDL
PKGWDVPLYFNFGNNTQAARAQLYVNGYQYGKFTGNVGPQTSFPVPEGILNYRGTNYVAL
SLWALESDGAKLGSFELSYTTPVLTGYGNVESPEQPKYEQRKGAY</sequence>
  </sequences>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Slightly soluble </value>
      <source>Official monographs</source>
    </property>
    <property>
      <kind>Isoelectric Point</kind>
      <value>4.5 </value>
      <source>Tanaka Y., et al. J biochem. 1975. </source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>102000.0</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>1887</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>168</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347911450</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0009344</id>
      <name>Lactose</name>
      <organism>Humans</organism>
      <actions>
        <action>cleavage</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links>
          <link>
            <ref-id>L2340</ref-id>
            <title>Australian Complementary Medicines Evaluation</title>
            <url>https://www.tga.gov.au/sites/default/files/cmec-minutes-47.pdf</url>
          </link>
        </links>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>